# Gene,Gene,# Disease,Disease,OMIM #,Disease Category,Inheritance,References for diseases without OMIM code,CONDE,UDER,
1,AAAS,1,Achalasia-addisonianism-alacrimia syndrome ,231550,Ocular,AR,,1,0,
2,ABCA4,2,"Stargardt disease, type 1",248200,Ocular,AR,,211,0,
,ABCA4,3,"Cone-rod dystrophy, type 3",604116,Ocular,AR,,18,0,
,ABCA4,4,"Retinitis pigmentosa, type 19",601718,Ocular,AR,,1,0,
3,ABCB11,5,"Cholestasis, progressive familial intrahepatic, type 2 ",601847,Metabolic,AR,,1,0,
4,ABCC6,6,Pseudoxanthoma elasticum,264800,Connective tissue ,AR,,17,0,
5,ABCD1,7,Adrenoleukodystrophy,300100,Neurological,XL,,1,0,
6,ABHD12,8,Retinitis pigmentosa,,Ocular,AR,"Nishiguchi et al., 2014",1,0,
7,ACSF3,9,Combined malonic and methylmalonic aciduria,614265,Metabolic,AR,,0,1,
8,ACTA1,10,"Congenital myopathy type 2A, typical",161800,Muscular,AD,,0,1,
9,ACTG1,11,"Baraitser-Winter sydrome, type 2",614583,Neurodevelopmental ,AD,,2,0,
10,ACVR1,12,Fibrodysplasia ossificans progressiva,135100,Skeletal,AD,,0,1,
11,ACVRL1,13,"Telangiectasia, hereditary hemorrhagic, type 2",600376,Cerebrovascular,AD,,0,2,
12,ADA2,14,"Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome",615688,"Hematological, Immunological and Lymphatic",AR,,0,2,
13,ADAM9,15,"Cone-rod dystrophy, type 9",612775,Ocular,AR,,1,0,
14,ADAMTS17,16,"Weill-marchesani syndrome, type 4",613195,Skeletal,AR,,1,0,
15,ADAMTSL4,17,Ectopia lentis et pupillae,225200,Ocular,AR,,1,0,
16,ADGRL1,18,"Developmental delay, behavioral abnormalities, and neuropsychiatric disorders",620065,Neurodevelopmental,AD,,0,1,
17,ADGRV1,19,"Usher syndrome, type 2C",605472,Ocular,AR,,3,0,
18,ADSL,20,Adenylosuccinase deficiency,103050,Metabolic,AR,,0,1,
19,AGRN,21,"Myasthenic syndrome, congenital, type 8, with pre- and postsynaptic defects",615120,Neurological,AR,,0,1,
20,AHDC1,22,Xia-Gibbs syndrome,615829,Neurodevelopmental,AD,,1,1,
21,AHI1,23,"Joubert syndrome, type 3",608629,Neurodevelopmental ,AR,,4,0,
22,AIPL1,24,"Leber congenital amaurosis, type 4",604393,Ocular,AR,,5,0,
23,AIRE,25,"Autoinmune polyendocrinopathy syndrome, type I, with or without reversible mataphyseal dysplasia",240300,"Hematological, Immunological and Lymphatic",AD,,2,0,
24,ALMS1,26,Alstrom syndrome,203800,Endocrine,AR,,10,0,
,ALMS1,27,Retinitis pigmentosa,,Ocular,AR,"Aldrees et al., 2019",1,0,
25,ALPK1,28,ROSAH syndrome,614979,"Hematological, Immunological and Lymphatic",AD,,1,1,
26,ANK3,29,"Inetellectual developmental disorder, type 37",615493,Neurodevelopmental ,AR,,1,0,
27,ANOSMIN1,30,"Hypogonadotropic hypogonadism with or without anosmia (Kallmann syndrome, type 1)",308700,Renal and Genitourinary,XL,,1,0,
28,ANTXR2,31,Hyaline fibromatosis syndrome,228600,Connective tissue,AR,,0,1,
29,APC,32,"Familial adenomatous polyposis, type 1",175100,Cancer,AD,,2,2,
30,APP,33,Cerebral amyloid angiopathy,605714,Neurological,AD,,0,1,
31,AR,34,Spinal and bulbar muscular atrophy,313200,Neurological,XL,,0,1,
,AR,35,Androgen insensitivity ,300068,Renal and Genitourinary,XL,,0,1,
32,ARG1,36,Argininemia,207800,Metabolic,AR,,1,0,
33,ARID1A,37,"Coffin-Siris syndrome, type 2",614607,Neurodevelopmental,AD,,0,1,
34,ARID1B,38,"Coffin-Siris syndrome, type 1",135900,Neurodevelopmental,AD,,0,1,
35,ARL3,39,Distrofia de cono-baston,,Ocular,AR,"Sheik et al., 2019",1,0,
36,ARL6,40,"Retinitis pigmentosa, type 55",613575,Ocular,AR,,2,0,
,ARL6,41,"Bardet-Biedl syndrome, type 3",600151,Endocrine,AR,,3,0,
,ARL6,42,Cone-rod dystrophy,,Ocular,AR,"Zahid, S. et al. 2018. ",1,0,
37,ARMC9,43,"Joubert syndrome, type 30",617622,Neurodevelopmental,AR,,1,0,
38,ASH1L,44,"Intellectual developmental disorder, type 52",617796,Neurodevelopmental,AD,,0,1,
39,ASXL3,45,Bainbridge-Ropers syndrome,615485,Neurodevelopmental,AD,,1,0,
40,ATM,46,"Breast cancer, susceptibility to}",114480,Cancer,AD,,0,3,
41,ATP1A3,47,CAPOS syndrome,601338,Neurological,AD,,0,1,
,ATP1A3,48,"Alternating hemiplegia of childhood, type 2 ",614820,Neurological,AD,,0,1,
42,ATP2A2,49,Darier disease,124200,Dermatological,AD,,0,1,
43,ATP2C1,50,Hailey-Hailey disease,169600,Dermatological,AD,,0,2,
44,ATP7A,51,Menkes disease,309400,Neurological,XL,,0,3,
45,ATXN2,52,"Spinocerebellar ataxia, type 2",183090,Neurological,AD,,0,2,
46,ATXN3,53,Machado-Joseph disease,109150,Neurological,AD,,0,1,
47,AVPR2,54,"Diabetes insipidus, nephrogenic, type 1",304800,Renal and Genitourinary,XL,,0,1,
48,BBS1,55,"Bardet-Biedl syndrome, type 1",209900,Endocrine,AR,,1,0,
49,BBS10,56,"Bardet-Biedl syndrome, type 10",615987,Endocrine,AR,,3,0,
50,BBS5,57,"Bardet-Biedl syndrome, type 5",615983,Endocrine,AR,,1,0,
51,BBS7,58,"Bardet-Biedl syndrome, type 7",615984,Endocrine,AR,,1,0,
52,BBS9,59,"Bardet-Biedl syndrome, type 9",615986,Endocrine,AR,,2,0,
53,BCL11B,60,"Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities",618092,Neurodevelopmental ,AD,,1,0,
54,BCOR,61,"Microphthalmia syndromic, type 2",300166,Ocular,XL,,2,0,
55,BEST1,62,"Macular dystrophy, vitelliform, type 2",153700,Ocular,AD,,41,0,
,BEST1,63,"Retinitis pigmentosa, type 50 ",613194,Ocular,AD,,1,0,
,BEST1,64,Vitreoretinochoroidopathy,193220,Ocular,AD,,3,0,
,BEST1,65,Bestrophinopathy,611809,Ocular,AR,,2,0,
56,BLM,66,Bloom syndrome,210900,Dermatological,AR,,2,0,
57,BRCA1,67,"Breast-ovarian cancer, familial, type 1",604370,Cancer,AD,,1,3,
58,BRCA2,68,"{Breast-ovarian cancer, familial, type 2}",612555,Cancer,AD,,1,4,
59,BRIP1,69,"Breast cancer, early onset, susceptibility",114480,Cancer,AD,,1,1,
60,BTD,70,Biotinidase deficiency,253260,Metabolic,AR,,0,1,
61,BTK,71,"Agammaglobulinemia, type 1",300755,"Hematological, Immunological and Lymphatic",XL,,0,2,
62,CABP4,72,"Cone-rod synaptic disorder, congenital nonprogressive",610427,Ocular,AR,,1,0,
63,CACNA1A,73,"Migraine, familial hemiplegic, type 1, with progressive cerebellar ataxia",141500,Neurological,AD,,0,4,
,CACNA1A,74,"Spinocerebellar ataxia, type 6",183086,Neurological,AD,,0,1,
64,CACNA1C,75,"Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures",62009,Neurodevelopmental,AD,,0,2,
65,CACNA1F,76,"Cone-rod dystrophy, type 3",300476,Ocular,XL,,3,0,
,CACNA1F,77,"Night blindness, congenital stationary (incomplete), type 2A",300071,Ocular,XL,,1,0,
,CACNA1F,78,Aland Island eye disease,300600,Ocular,XL,,6,0,
66,CAPN5,79,"Vitreoretinopathy, neovascular inflammatory",193235,Ocular,AD,,1,0,
67,CAPN3,80,"Muscular dystrophy, limb-girdle, type 1 ",253600,Muscular,AR,,0,1,
68,CASP10,81,"Autoimmune lymphoproliferative syndrome, type II",603909,"Hematological, Immunological and Lymphatic",AD,,0,1,
69,CD46,82,"{Hemolytic uremic syndrome, atypical, susceptibility to, type 2}",612922,Renal and Genitourinary,AD,,0,1,
70,CDC42BPB,83,Chilton-Okur-Chung neurodevelopmental syndrome,619841,Neurodevelopmental,AD,,0,1,
71,CDH23,84,"Usher syndrome, type ID/F",601067,Ocular,AR,,6,0,
72,CDH3,85,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy",225280,Dermatological,AR,,2,0,
73,CDHR1,86,"Retinitis pigmentosa, type 65",613660,Ocular,AR,,2,0,
,CDHR1,87,"Cone-rod dystrophy, type 15",613660,Ocular,AR,,1,0,
,CDHR1,88,"Retinitis pigmentosa, type 65",613660,Ocular,AR,,1,0,
74,CDKL5,89,"Developmental and epileptic encephalopathy, type 2",300672,Neurodevelopmental,AD,,0,1,
75,CDKN2A,90,{Melanoma-pancreatic cancer syndrome},606719,Cancer,AD,,0,2,
,CDKN2A,91,"{Melanoma, cutaneous malignant, type 2}",155601,Cancer,AD,,0,6,
76,CELF2,92,"Developmental and epileptic encephalopathy, type 97",619561,Neurodevelopmental,AD,,0,1,
77,CELSR1,93,"Lymphatic malformation, type 9",619319,"Hematological, Immunological and Lymphatic",AD,,0,1,
78,CENPJ,94,"Microcephaly, type 6, primary",608393,Neurodevelopmental,AR,,0,1,
79,CEP152,95,Seckel syndrome 5,613823,Neurodevelopmental,AR,,0,1,
80,CEP250,96,Retinitis pigmentosa,,Ocular,AR,"Huang et al., 2019",1,0,
81,CEP290,97,Retnitis pigmentosa,,Ocular,AR,"Testa et al., 2021",3,0,
,CEP290,98,"Leber congenital amaurosis, type 10",611755,Ocular,AR,,4,0,
,CEP290,99,"Joubert syndrome, type 5",610188,Ocular,AR,,1,0,
82,CEP78,100,Cone-rod dystrophy and hearing loss,617236,Ocular,AR,,1,0,
83,CERKL,101,"Retinitis pigmentosa, type 26",608380,Ocular,AR,,15,0,
84,CFAP418,102,"Retinitis pigmentosa, type 64",614500,Ocular,AR,,1,0,
85,CHD3,103,Snijders Blok-Campeau syndrome,618205,Neurodevelopmental,AD,,0,2,
86,CHD7,104,CHARGE syndrome,214800,Ocular,AD,,8,0,
87,CHD8,105,Intellectual developmental disorder with autism and macrocephaly,615032,Neurodevelopmental,AD,,0,1,
88,CHN1,106,"Duane retraction syndrome, type 2 ",604356,Ocular,AD,,1,0,
89,CHM,107,Choroideremia,303100,Ocular,XL,,40,0,
90,CHRDL1,108,"Megalocornea, X-linked",309300,Ocular,XL,,1,0,
91,CHST6,109,Macular corneal dystrophy,217800,Ocular,AR,,2,0,
92,CILK1,110,"{Epilepsy, juvenile myoclonic, susceptibility to, 10}",617924,Neurodevelopmental,AD,,1,0,
93,CLCN4,111,Raynaud-Claes syndrome,300114,Neurodevelopmental,XL,,0,1,
94,CLCNKB,112,"Bartter syndrome, type 3",607364,Renal and Genitourinary,AR,,0,1,
95,CLN3,113,"Ceroid lipofuscinosis, neuronal, type 3",204200,Neurological,AR,,2,0,
,CLN3,114,Retinitis pigmentosa ,,Ocular,AR,"Wang et al., 2014",10,0,
96,CLRN1,115,"Usher syndrome, type 3A",276902,Ocular,AR,,1,0,
,CLRN1,116,"Retinitis pigmentosa, type 61",614180,Ocular,AR,.,1,0,
97,CNGA3,117,"Achromatopsia, type 2",216900,Ocular,AR,,4,0,
98,CNGB1,118,"Retinitis pigmentosa, type 45",613767,Ocular,AR,,2,0,
99,CNGB3,119,"Achromatopsia, type 3",262300,Ocular,AR,,4,0,
100,CNNM4,120,Jalili syndrome,217080,Ocular,AR,,5,0,
101,CNTNAP1,121,"Hypomyelinating neuropathy, congenital, type 3",618186,Neurological,AR,,0,1,
102,COL11A1,122,"Stickler syndrome, type II",604841,Connective tissue,AD,,2,0,
103,COL18A1,123,"Knobloch syndrome, type 1",267750,Ocular,AR,,2,0,
104,COL1A2,124,"Osteogenesis imperfecta, type II",166210,Skeletal,AD,,0,1,
105,COL2A1,125,"Stickler syndrome, Type I",108300,Connective tissue ,AD,,5,0,
,COL2A1,126,"Stickler syndrome, nonsyndromic ocular",609508,Connective tissue ,AD,,15,0,
106,COL4A1,127,Brain small vessel disease 1 with or without ocular anomalies,175780,Neurological,AD,,3,0,
,COL4A1,128,"?Retinal arteries, tortuosity of",180000,Ocular,AD,,1,0,
,COL4A1,129,COL4A1-Related Disorders,,Cerebrovascular,AD,Plaisier et al. 2016,0,1,
107,COL4A3,130,"Alport syndrome, type 3A",104200,Renal and Genitourinary,AD,,0,4,
108,COL4A4,131,"Alport syndrome, type 2",203780,Renal and Genitourinary,AR,,1,0,
109,COL5A1,132,"Ehlers-Danlos syndrome, classic type 1",130000,Connective tissue,AD,,1,0,
110,COL5A2,133,"Ehlers-Danlos syndrome, classic type 2",130010,Connective tissue,AD,,1,0,
111,COL6A1,134,Ullrich muscular dystrophy,254090,Muscular,AD,,0,1,
,COL6A1,135,"Bethlem myopathy, type 1A ",158810,Muscular,AD,,3,0,
112,COL8A2,136,"Corneal dystrophy, Fuchs endothelial type 1 ",136800,Ocular,AD,,1,0,
113,COLQ,137,"Myasthenic syndrome, congenital, type 5",603034,Neurological,AR,,0,1,
114,COQ4,138,"Coenzyme Q10 deficiency, primary, type 7",616276,Neurological,AR,,0,2,
115,CP,139,Aceruloplasminemia,604290,Neurological,AR,,0,1,
116,CPAMD8,140,"Anterior segment dysgenesis, type 8",617319,Ocular,AR,,0,2,
117,CRB1,141,"Retinitis pigmentosa, nanophthalmos",,Ocular,AR,"Zenteno et al., 2011",8,0,
,CRB1,142,"Leber congenital amaurosis, type 8",613835,Ocular,AR,,17,0,
,CRB1,143,"Retinitis pigmentosa, type 12",600105,Ocular,AR,,14,0,
118,CREBBP,144,"Rubinstein-Taybi syndrome, type 1",180849,Neurodevelopmental,AD,,0,1,
119,CRX,145,Cone-rod dystrophy. type 2,120970,Ocular,AD,,7,0,
120,CRYAA,146,"Cataract, congenital, type 9",604219,Ocular,AD,,3,0,
121,CRYBB2,147,"Cataract, congenital, type 3",601547,Ocular,AD,,2,0,
122,CRYGA,148,"Cataract, congenital ",,Ocular,AD,"Astiazarán et al., 2018",3,0,
123,CRYGC,149,"Cataract, congenital, type 2",604307,Ocular,AD,,2,0,
124,CRYGD,150,"Cataract, congenital, type 4",115700,Ocular,AD,,2,0,
125,CSF1R,151,"Leukoencephalopathy, diffuse hereditary, with spheroids",221820,Neurological,AD,,1,0,
126,CSNK2A1,152,Okur-Chung neurodevelopmental syndrome,617062,Neurodevelopmental,AD,,0,2,
127,CTSK,153,Pycnodysostosis,265800,Skeletal,AR,,1,0,
128,CYB5R3,154,"Methemoglobinemia, type I",250800,"Hematological, Immunological and Lymphatic",AR,,0,3,
129,CYP1B1,155,"Glaucoma, type 3A, primary open angle, congenital, juvenile or adult onset",231300,Ocular,AR,,26,0,
130,CYP1B1,156,"Anterior segment dysgenesis, type 6",617315,Ocular,AR,,3,0,
131,CYP21A2,157,"Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency",201910,Metabolic ,AR,,0,2,
132,CYP2UI,158,"Spastic paraplegia, type 56",615030,Neurological,AR,,1,0,
133,CYP4V2,159,Bietti crystalline corneoretinal dystrophy ,210370,Ocular,AR,,1,0,
134,DGUOK,160,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, type 4",617070,Neurological,AR,,1,0,
135,DHTKD1,161,"?Charcot-Marie-Tooth disease, axonal, type 2Q",615025,Neurological,AD,,0,1,
136,DLG3,162,"Intellectual developmental disorder, type 90",300850,Neurodevelopmental,XL,,0,1,
137,DLL3,163,"Spondylocostal dysostosis, type 1",277300,Skeletal,AR,,0,1,
138,DMD,164,Duchenne muscular dystrophy,310200,Muscular,XL,,0,3,
139,DMPK,165,"Myotonic dystrophy, type 1",160900,Neurological,AD,,0,11,
140,DNAH5,166,"Ciliary dyskinesia, primary, type 3, with or without situs inversus",608644,Cardiovascular,AR,,0,2,
141,DNAJB2,167,"Neuronopathy, distal hereditary motor, type 5",614881,Neurological,AR,,1,0,
142,DNMT3A,168,Tatton-Brown-Rahman syndrome,615879,Neurodevelopmental,AD,,0,1,
143,DOCK8,169,"Hyper-IgE syndrome, type 2",243700,"Hematological, Immunological and Lymphatic",AR,,1,0,
144,DRAM2,170,"Cone-rod dystrophy, type 21",616502,Ocular,AR,,3,0,
145,DSG2,171,"Arrhythmogenic right ventricular dysplasia, type 10",610193,Cardiovascular,AD,,0,2,
146,DSP,172,"Arrhythmogenic right ventricular dysplasia, type 8",607450,Cardiovascular,AD,,0,2,
147,DYNC1I2,173,Neurodevelopmental disorder with microcephaly and structural brain anomalies,618492,Neurodevelopmental,AR,,0,1,
148,DYSF,174,"Muscular dystrophy, limb-girdle, type 2 ",253601,Muscular,AR,,0,1,
149,EBP,175,Chondrodysplasia punctata,302960,Skeletal,XL,,2,0,
150,EEF1A2,176,"Developmental and epileptic encephalopathy, type 33",616409,Neurodevelopmental,AD,,0,1,
151,EFEMP1,177,Doyne Honeycomb retinal dystrophy,126600,Ocular,AD,,14,0,
152,EFNB1,178,Craniofrontonasal dysplasia,304110,Skeletal,XL,,5,0,
153,EFTUD2,179,"Mandibulofacial dysostosis, Guion-Almeida type",610536,Skeletal,AD,,1,0,
154,EHMT1,180,"Kleefstra syndrome, type 1",610253,Neurodevelopmental,AD,,1,1,
155,ELOVL5,181,"Spinocerebellar ataxia, type 38",615957,Neurological,AD,,0,1,
156,EPHA2,182,"Cataract, congenital, type 6",116600,Ocular,AD,,4,0,
157,EYA1,183,"Branchiootorenal syndrome, type 1, with or without cataracts",113650,Renal and Genitourinary,AD,,0,1,
158,EYS,184,"Retinitis pigmentosa, type 25",602772,Ocular,AR,,25,0,
159,FA2H,185,"Spastic paraplegia, type 35",612319,Neurological,AR,,0,1,
160,FAM111B,186,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis ",615704,Dermatological,AD,,0,2,
161,FAM161A,187,"Retinitis pigmentosa, type 28",606068,Ocular,AR,,5,0,
162,FANCA,188,"Fanconi anemia, complementation group A",227650,"Hematological, Immunological and Lymphatic",AR,,0,1,
163,FBLN5,189,"Macular degeneration, age-related, type 3",608895,Ocular,AD,,1,0,
164,FBN1,190,"Ectopia lentis, familial",129600,Ocular,AD,,11,0,
,FBN1,191,"Weill-Marchesani syndrome, type 2",608328,Skeletal,AD,,1,0,
,FBN1,192,Marfan syndrome,154700,Connective tissue,AD,,8,10,
165,FBP1,193,"Fructose-1,6-bisphosphatase deficiency",229700,Metabolic,AR,,0,2,
166,FDXR,194,"Multiple mitochondrial dysfunctions syndrome, type 9B ",620887,Neurodevelopmental,AR,,1,0,
167,FGFR1,195,"Encephalocraniocutaneous lipomatosis, somatic mosaic",613001,Dermatological,AD (somatic),,1,0,
168,FGFR2,196,Apert syndrome,101200,Skeletal,AD,,1,0,
,FGFR2,197,Crouzon Syndrome,123500,Skeletal,AD,,5,1,
,FGFR2,198,Saethre-Chotzen syndrome,101400,Skeletal,AD,,0,1,
169,FGFR3,199,Hypochondroplasia,146000,Skeletal,AD,,0,2,
170,FGF10,200,"LADD syndrome, type 3 ",620193,Ocular,AD,,1,0,
171,FKRP,201,"Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5",606612,Neurodevelopmental,AR,,0,1,
172,FKTN,202,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",253800,Muscular,AR,,0,1,
173,FLNA,203,"Otopalatodigital syndrome, type I ",311300,Skeletal,XL,,1,0,
174,FOXC1,204,"Anterior segment dysgenesis, type 3",601631,Ocular,AD,,10,0,
,FOXC1,205,"Axenfeld-Rieger syndrome, type 3",602482,Ocular,AD,,16,1,
,FOXC1,206,De Hauwere Syndrome,,Cardiovascular,AD,"Reis et al., 2023",0,1,
175,FOXE3,207,"Anterior segment dysgenesis, type 2",610256,Ocular,AR,,21,0,
176,FOXG1,208,"Rett syndrome, congenital variant",613454,Neurodevelopmental,AD,,0,2,
177,FOXL2,209,"Blepharophimosis, epicanthus inversus, and ptosis, types 1 and 2",110100,Ocular,AD,,24,0,
178,FOXP1,210,Intellectual developmental disorder with language impairment with or without autistic features,613670,Neurodevelopmental,AD,,0,1,
179,FREM1,211,Manitoba oculotrichoanal syndrome,248450,Ocular,AR,,1,0,
180,FTL,212,Hyperferritinemia-cataract syndrome,600886,"Hematological, Immunological and Lymphatic",AD,,2,0,
181,FXN,213,Friedreich ataxia,229300,Neurological,AR,,0,1,
182,FZD4,214,"Exudative vitreoretinopathy, type 1",133780,Ocular,AD,,1,0,
183,G6PD,215,"Anemia, congenital, nonspherocytic hemolytic, type 1, G6PD deficient",300908,"Hematological, Immunological and Lymphatic",XL,,2,2,
184,GABBR2,216,"Developmental and epileptic encephalopathy, type 59",617904,Neurodevelopmental,AD,,0,1,
185,GABRA2,217,"Developmental and epileptic encephalopathy, type 78",618557,Neurodevelopmental,AD,,0,1,
186,GALC,218,Krabbe disease,245200,Neurodevelopmental,AR,,0,2,
187,GALK1,219,Galactokinase deficiency ,230200,Metabolic,AR,,4,0,
188,GALNS,220,"Mucopolysaccharidosis, type IVA",253000,Metabolic ,AR,,1,0,
189,GAN,221,Giant axonal neuropathy-1,256850,Neurological,AR,,0,1,
190,GANAB,222,"Polycystic kidney disease, type 3",600666,Renal and Genitourinary,AD,,0,1,
191,GBA,223,"Parkinson disease, late-onset, susceptibility to",168600,Neurological,AD,,0,1,
,GBA,224,"Gaucher disease, type I",230800,"Hematological, Immunological and Lymphatic",AR,,0,1,
192,GBF1,225,"Charcot-Marie-Tooth disease, axonal, type 2GG",606483,Neurological,AD,,0,2,
193,GCDH,226,"Glutaric aciduria, type I",231670,Metabolic,AR,,5,0,
194,GCK,227,"MODY, type II",125851,Metabolic ,AD,,2,1,
195,GDAP1,228,"Charcot-Marie-Tooth disease, axonal, type 2K",607831,Neurological,AD,,1,0,
196,GDF6,229,"Microphthalmia isolated, type 4",613094,Ocular,AD,,4,0,
197,GFAP,230,Alexander disease,203450,Neurological,AD,,0,1,
198,GJA1 ,231,Oculodentodigtal dysplasia,164200,Ocular,AD,,4,0,
199,GJA3,232,"Cataract, congenital, type 14",601885,Ocular,AD,,1,0,
200,GJA8,233,"Cataract, congenital, type 1",116200,Ocular,AD,,2,0,
201,GJB2,234,Keratitis-ichthyosis-deafness syndrome,148210,Dermatological,AD,,2,0,
202,GMPPA,235,"Alacrima, Achalasia, and impaired intellectual development syndrome",615510,Neurodevelopmental ,AR,,2,0,
203,GNAL,236,"Dystonia, type 25",615073,Neurological,AD,,2,0,
204,GNAS,237,"McCune-Albright syndrome, somatic mosaic",174800,Endocrine,AD (somatic),,1,0,
205,GNAT1,238,"Night blindness, congenital stationary, type 1G",616389,Ocular,AR,,2,0,
206,GNB1,239,"Intellectual developmental disorder, type 42",616973,Neurodevelopmental,AD,,0,1,
207,GPR143,240,"Ocular albinism, type I",300500,Ocular,XL,,6,0,
208,GPR179,241,"Night blindness, congenital stationary (complete), type 1E",614565,Ocular,AR,,1,0,
209,GRHPR,242,"Hyperoxaluria, primary, type II",260000,Renal and Genitourinary,AR,,0,1,
210,GRIA2,243,Neurodevelopmental disorder with language impairment and behavioral abnormalities,618917,Neurodevelopmental,AD,,0,2,
211,GSDME,244,"Deafness, type 5 ",600994,Neurological,AD,,1,0,
212,GSN,245,"Amyloidosis, Finnish type",105120,Ocular,AD,,3,0,
213,GUCA1A,246,"Cone-rod dystrophy, type 14",602093,Ocular,AD,,3,0,
214,GUCA1B,247,"Retinitis pigmentosa, type 48",613827,Ocular,AD,,1,0,
215,GUCY2D,248,"Leber congenital amaurosis, type 1",204000,Ocular,AR,,19,0,
,GUCY2D,249,"Cone-rod dystrophy, type 6",601777,Ocular,AD,,9,0,
216,GZF1,250,"Joint laxity, short stature, and myopia",617662,Connective tissue,AR,,6,0,
217,HBA1,251,"Erythrocytosis, familial, type 7",617981,"Hematological, Immunological and Lymphatic",AD,,1,0,
218,HBA2,252,"Erythrocytosis, familial, type 7",617981,"Hematological, Immunological and Lymphatic",AD,,1,0,
,HBA2,253,"Thalassemia, alpha-",604131,"Hematological, Immunological and Lymphatic",AR,,1,1,
219,HEXA,254,Tay-Sachs disease,272800,Neurodevelopmental,AR,,0,1,
220,HFE,255,"Hemochromatosis, type 1",235200,"Hematological, Immunological and Lymphatic",AR,,0,1,
221,HGSNAT,256,"Retinitis pigmentosa, type 73",616544,Ocular,AR,,1,0,
,HGSNAT,257,Mucopolysaccharidosis type IIIC (Sanfilippo C),252930,Neurodevelopmental,AR,,2,1,
222,HMBS,258,"Porphyria, acute intermittent",176000,"Hematological, Immunological and Lymphatic",AD,,1,0,
223,HMCN1,259,"Macular degeneration, age-related, type 1",603075,Ocular,AD,,1,0,
224,HNF1A,260,"MODY, type III",600496,Endocrine,AD,,0,3,
225,HNRNPH2,261,"Intellectual developmental disorder, Bain type",300986,Neurodevelopmental,XL,,0,1,
226,HTT,262,Huntington disease,143100,Neurological,AD,,0,1,
227,IARS2,263,"Cataracs, growth hormone deficiency, sensory neuropathy, sensoryneural hearing loss, and skeletal dysplasia",616007,Neurodevelopmental ,AR,,1,0,
228,IDH3B,264,"Retinitis pigmentosa, type 46",612572,Ocular,AR,,1,0,
229,IFT140,265,"Retinitis pigmentosa, type 80",617781,Ocular,AR,,8,0,
230,IMPG1,266,"Retinitis pigmentosa, type 91",153870,Ocular,AD,,4,0,
231,IMPG2,267,"Retinitis pigmentosa, type 56",613581,Ocular,AR,,4,0,
,,268,"Macular dystrophy, vitelliform, 5",	616152,Ocular,AD,,9,0,
232,IRF2BPL,269,"Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures",618088,Neurodevelopmental,AD,,0,1,
233,JAG1,270,"Alagille syndrome, type 1",118450,Ocular,AD,,3,1,
234,KCNB1,271,"Developmental and epileptic encephalopathy, type 26",616056,Neurodevelopmental,AD,,0,1,
235,KCNC2,272,"Developmental and epileptic encephalopathy, type 103",619913,Neurodevelopmental,AD,,0,1,
236,KCND3,273,"Spinocerebellar ataxia, type 19",607346,Neurodevelopmental,AD,,1,0,
237,KCNH2,274,"Long QT syndrome, type 2",613688,Cardiovascular ,AD,,2,2,
,KCNH2,275,"Short QT syndrome, type 1",609620,Cardiovascular,AD,,0,1,
238,KCNJ11,276,"Hyperinsulinemic hypoglycemia, familial, type 2",601820,Endocrine,AD,,0,1,
239,KCNJ2,277,Andersen cardiodysrhythmic periodic paralysis,170390,Cardiovascular,AD,,0,1,
240,KCNQ1,278,"Long QT syndrome, type 1 ",192500,Cardiovascular,AD,,0,1,
241,KCNQ2,279,"Developmental and epileptic encephalopathy, type 7",613720,Neurodevelopmental,AD,,0,2,
242,KCNV2,280,"Retinal cone dystrophy, type 3B",610356,Ocular,AR,,2,0,
243,KDM1A,281,"Cleft palate, psychomotor retardation, and distinctive facial features",616728,Neurodevelopmental,AD,,0,1,
244,KDM5A,282,KDM5A-Associated Disorders,,Neurodevelopmental,AD,"El Hayek et al., 2020",0,1,
245,KDM5B,283,KDM5B-Associated Disorders,,Neurodevelopmental,AD,"Borroto et al., 2024",0,1,
246,KDM5C,284,"Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type",300534,Neurodevelopmental,XL,,0,1,
247,KERA,285,"Cornea plana, type 2",217300,Ocular,AR,,3,0,
248,KIAA1549,286,"Retinitis pigmentosa, type 86",618613,Ocular,AR,,1,0,
249,KIF1A,287,NESCAV syndrome ,614255,Neurodevelopmental,AD,,0,1,
250,KIF11,288,"Microcephaly with or without chorioretinopathy, lymphedema or impaired intellectual developmen",152950,Neurodevelopmental,AD,,3,0,
251,KIF21A,289,"Fibrosis of extraocular muscles congenital, type 1",135700,Ocular,AD,,6,0,
252,KIF2A,290,"Cortical dysplasia, complex, with other brain malformations, type 3",615411,Neurodevelopmental,AD,,0,1,
253,KIF5A,291,"Spastic paraplegia, type 10",604187,Neurological,AD,,0,1,
254,KIF7,292,Acrocallosal syndrome,200990,Neurodevelopmental,AR,,1,0,
255,KIZ,293,"Retinitis pigmentosa, type 69",615780,Ocular,AR,,1,0,
256,KMT2A,294,Wiedemann-Steiner syndrome,605130,Neurodevelopmental,AD,,0,4,
257,KMT2D,295,"Kabuki syndrome, type 1",147920,Neurodevelopmental,AD,,0,3,
258,KRAS,296,"Oculoectodermal syndrome, somatic",600268,Dermatological,AD (somatic),,3,0,
,KRAS,297,"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaicism",163200,Dermatological,AD (somatic),,3,0,
,KRAS,298,"Noonan syndrome, type 3",609942,Neurodevelopmental,AD,,0,1,
259,KRT10,299,"Epidermolytic hyperkeratosis, type 2A",620150,Dermatological,AD,,1,0,
260,LAMA2,300,"Muscular dystrophy, congenital, merosin deficient or partially deficient",607855,Muscular,AR,,0,2,
261,LBR,301,Reynolds syndrome,613471,"Hematological, Immunological and Lymphatic",AD,,0,1,
262,LCA5,302,"Leber congenital amaurosis, type 5",604537,Ocular,AR,,3,0,
263,LDLR,303,"Hypercholesterolemia, familial, type 1",143890,Metabolic ,AD,,1,4,
264,LMNA,304,Hutchinson-Gilford progeria,176670,Cardiovascular,AD,,0,1,
265,LOXL1,305,"Exfoliation syndrome, susceptibility ",177650,Ocular,AD,,1,0,
266,LPIN1,306,"Myoglobinuria, acute recurrent",268200,Muscular,AR,,0,1,
267,LPL,307,"Lipase deficiency, combined",246650,Metabolic,AR,,1,0,
268,LRAT,308,"Leber congenital amaurosis, type 14",613341,Ocular,AR,,2,0,
269,LRP2,309,Donnai-Barrow syndrome,222448,Ocular,AR,,2,0,
270,LRP5,310,"Exudative vitreoretinopathy, type 4",601813,Ocular,AR,,4,0,
,LRP5,311,Osteoporosis-pseudoglioma syndrome,259770,Skeletal,AR,,1,0,
271,LRRK2,312,Parkinson disease 8,607060,Neurological,AD,,0,3,
272,LYST,313,Chediak-Higashi syndrome,214500,Dermatological,AR,,0,1,
273,MAPK8IP3,314,Neurodevelopmental disorder with or without variable brain abnormalities,618443,Neurodevelopmental,AD,,0,1,
274,MCPH1,315,Hereditary Breast Cancer Susceptibility,,Cancer,AD,"Mantere et al., 2016",0,1,
275,MECP2,316,Rett syndrome ,312750,Neurodevelopmental,XL,,0,2,
276,MED12,,MED12-Related Disorders,,Neurodevelopmental,XL,"Lyons et al., 2021",0,2,
277,MEFV,318,Familial Mediterranean fever,134610,"Hematological, Immunological and Lymphatic",AD,,0,3,
278,MERTK,319,"Retinitis pigmentosa, type 38",613862,Ocular,AR,,5,0,
279,MFN2,320,"Hereditary motor and sensory neuropathy, type VIA",601152,Neurological,AD,,1,1,
280,MFRP,321,"Nanophthalmos, type 2",609549,Ocular,AR,,1,0,
,MFRP,322,"Nanophthalmos, retinitis pigmentosa, foveoschisis, optic disk drusen",,Ocular,AR,"Ayala-Ramirez et al., 2006",6,0,
281,MFSD8,323,Macular dystrophy with central cone involvement,616170,Ocular,AR,,1,0,
,MFSD8 ,324,"Ceroid lipofuscinosis, neuronal, type 7",610951,Neurodevelopmental,AR,,0,1,
282,MITF,325,"Waardenburg syndrome, type 2A",193510,Dermatological,AD,,1,2,
283,MKKS,326,"Bardet-Biedl syndrome, type 6",605231,Endocrine,AR,,2,0,
284,MSH6,327,"Lynch syndrome, type 5 ",614350,Cancer,AD,,1,0,
285,MSX2,328,"Parietal foramina, type 1 ",168500,Skeletal,AD,,1,0,
286,MT-ATP6,329,"Leigh syndrome, mithocondrial",500017,Neurological,MT,,0,0,
,MT-ATP6,330,"Neuropathy, ataxia, and retinitis pigmentosa",551500,Neurological,MT,,1,4,
287,MT-ND4,331,Leber Hereditary Optic Neuropathy; LHON,535000,Ocular,MT,,5,0,
288,MT-ND6,332,Leber Hereditary Optic Neuropathy; LHON,535000,Ocular,MT,,0,2,
289,MT-TK,333,Myoclonic Epilepsy with Ragged Red Fibers,545000,Muscular,MT,,1,0,
290,MT-TL1,334,"Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes; MELAS",540000,Neurological,MT,,0,3,
291,MT-TV,335,"Charcot-Marie-Tooth Disease, Axonal, Mitochondrial; CMTMA",500013,Neurological,MT,,0,1,
292,MTMT1,336,"Myopathy, centronuclear",310400,Muscular,XL,,0,1,
293,MTOR,337,Smith-Kingsmore syndrome,616638,Neurodevelopmental,AD,,0,1,
294,MTSS2,338,Intellectual developmental disorder with ocular anomalies and distinctive facial features,620086,Neurodevelopmental,AD,,0,1,
295,MYBPC3,339,"Cardiomyopathy, hypertrophic, type 4",115197,Cardiovascular,AD,,0,4,
296,MYH2,340,"Congenital myopathy, type 6, with ophthalmoplegia",605637,Muscular,AD,,1,0,
297,MYO7A,341,"Usher syndrome, type 1B",276900,Ocular,AR,,10,0,
298,MYOC,342,"Glaucoma, primary open angle, type 1A",137750,Ocular,AD,,37,0,
299,MYRF,343,Cardiac-urogenital syndrome,618280,Cardiovascular,AD,,2,0,
300,MYTL1,344,"Intellectual developmental disorder, type 39",616521,Neurodevelopmental,AD,,1,0,
301,NAA10,345,"Microphthalmia syndromic, type 1",309800,Ocular,XL,,4,0,
302,NAA15,346,"Intellectual developmental disorder, type 50, with behavioral abnormalities",617787,Neurodevelopmental,AD,,0,3,
303,NBEA,347,Neurodevelopmental disorder with or without early-onset generalized epilepsy,619157,Neurodevelopmental,AD,,0,1,
304,NDP,348,Norrie disease,310600,Ocular,XL,,37,2,
305,NF1,349,Neurofibromatosis-Noonan syndrome,601321,Dermatological,AD,,0,1,
,NF1,350,"Neurofibromatosis, type 1",162200,Dermatological,AD,,1,2,
306,NF2,351,"Schwannomatosis, vestibular",101000,Neurological,AD,,1,0,
307,NIPBL,352,"Cornelia de Lange syndrome, type 1",122470,Neurodevelopmental,AD,,0,1,
308,NLRP7,353,"Hydatidiform mole, recurrent, type 1 ",231090,Renal and Genitourinary,AR,,1,0,
309,NMNAT1,354,"Leber congenital amaurosis, type 9",608553,Ocular,AR,,2,0,
310,NOD2,355,Blau syndrome,186580,"Hematological, Immunological and Lymphatic",AD,,1,0,
311,NPC1,356,"Niemann-Pick disease, type C1",257220,Metabolic,AR,,1,0,
312,NPHS2,357,"Nephrotic syndrome, type 2",600995,Renal and Genitourinary,AR,,0,1,
313,NR2E3,358,"Retinitis pigmentosa, type 37",611131,Ocular,AD,,8,0,
314,NRL,359,"Retinitis pigmentosa, type 27",613750,Ocular,AD,,5,0,
315,NSD1,360,Sotos syndrome,117550,Neurodevelopmental,AD,,1,4,
316,NSD2,361,Rauch-Steindl syndrome,619695,Neurodevelopmental,AD,,0,4,
317,NTRK2,362,"Developmental and epileptic encephalopathy, type 58",617830,Neurodevelopmental,AD,,0,1,
318,NYX,363,"Night blindness, congenital stationary (complete), type 1A,",310500,Ocular,XL,,1,0,
319,OAT,364,Gyrate atrophy of choroid and retina,258870,Metabolic ,AR,,10,0,
320,OCA2,365,"Albinism, oculocutaneous, type II",203200,Dermatological,AR,,6,0,
321,OCRL,366,Lowe syndrome,309000,Neurodevelopmental,XL,,2,0,
322,OPA1,367,"Optic atrophy, type 1",165500,Ocular,AD,,6,0,
,OPA1,368,Behr syndrome,210000,Ocular,AR,,1,0,
323,OPTN,369,"Amyotrophic lateral sclerosis, type12, with or witout frontotemporal dementia",613435,Neurological,AD,,1,0,
324,OTX2,370,"Microphthalmia syndromic, type 5",610125,Ocular,AD,,5,0,
325,OTX2,371,"Retinal dystrophy, early-onset, with or without pituitary dysfunction",610125,Ocular,AD,,1,0,
326,PABPN1,372,Oculopharyngeal muscular dystrophy,164300,Neurological,AD,,185,0,
327,PACS1,373,Schuurs-Hoeijmakers syndrome,615009,Neurodevelopmental,AD,,2,1,
328,PALB2,374,"{Breast-ovarian cancer, familial, susceptibility to, 5}",620442,Cancer,AD,,0,3,
329,PANK2,375,"Neurodegeneration with brain iron accumulation, type 1",234200,Neurodevelopmental,AR,,14,0,
330,PAX3,376,"Wardenburg syndrome, type 1",193500,Dermatological,AD,,7,0,
331,PAX6,377,Aniridia,106210,Ocular,AD,,31,0,
332,PCARE,378,"Retinitis pigmentosa, type 54",613428,Ocular,AR,,14,0,
,PCARE,379,"Cone-rod dystrophy, type 23",613428,Ocular,AR,,5,0,
333,PCDH15,380,"Usher syndrome, type 1D/F digenic",601067,Ocular,AR,,2,0,
334,PDE6A,381,"Retinitis pigmentosa, type 43",613810,Ocular,AR,,6,0,
335,PDE6B,382,"Retinitis pigmentosa, type 40",613801,Ocular,AR,,5,0,
336,PDE6H,383,Retinitis pigmentosa,610024,Ocular,AD,,1,0,
337,PDHA1,384,Pyruvate dehydrogenase E1-alpha defiency,312170,Metabolic,XL,,1,0,
338,PEX1,385,"Heimler syndrome, type 1",234580,Metabolic,AR,,2,0,
339,PEX26,386,"Peroxisome biogenesis disorder, type 7A (Zellweger)",614872,Metabolic,AR,,1,0,
340,PEX6,387,"Heimler syndrome, type 2",616617,Metabolic,AR,,1,0,
341,PIEZO1,388,"Lymphatic malformation, type 6",616843,"Hematological, Immunological and Lymphatic",AR,,0,1,
342,PIK3R1,389,SHORT syndrome,269880,Skeletal ,AD,,1,0,
343,PIKFYVE,390,Corneal fleck dystrophy,121850,Ocular,AD,,2,0,
344,PITPNM3,391,"Cone-rod dystrophy, type 5",600977,Ocular,AD,,1,0,
345,PITX2,392,"Axenfeld-Rieger syndrome, type 1",180500,Ocular,AD,,6,0,
346,PKD1,393,"Polycystic kidney disease, type 1",173900,Renal and Genitourinary,AD,,3,6,
347,PKHD1,394,"Polycystic kidney disease, type 4, with or without hepatic disease",263200,Renal and Genitourinary,AR,,0,1,
348,PLP1,395,Pelizaeus-Merzbacher disease,312080,Neurodevelopmental,XL,,0,3,
349,POC1B,396,"Cone-rod dystrophy, type 20",615973,Ocular,AR,,9,0,
350,POLA1,397,"Pigmentary disorder, reticulate, with systemic manifestations",301220,Dermatological,XL,,0,1,
351,POLG,398,"Progressive external ophthalmoplegia, type 1",157640,Ocular,AD,,0,5,
352,POLR2A,399,Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities,618603,Neurodevelopmental,AD,,0,1,
353,POLR3A,400,"Leukodystrophy, hypomyelinating, type 7, with or without oligodontia and/or hypogonadotropic hypogonadism",607694,Neurodevelopmental,AR,,0,1,
354,POLRMT,401,"Combined oxidative phosphorylation deficiency, type 55",619743,Neurological,AR,,0,1,
355,PPARG,402,"Lipodystrophy, familial partial, type 3",604367,Endocrine,AD,,1,0,
356,PPP1CB,403,"Noonan syndrome-like disorder with loose anagen hair, type 2",617506,Neurodevelopmental,AD,,0,1,
357,PPT1,404,"Ceroid lipofuscinosis, neuronal, type 1",256730,Neurological,AR,,1,0,
358,PRCD,405,"Retinitis pigmentosa, type 36",610599,Ocular,AR,,2,0,
359,PRDM13,406,"Macular dystrophy, retinal, type 1, North Carolina type, MCDR1",136550,Ocular,AD,,4,0,
360,PREPL,407,"Myasthenic syndrome, congenital, type 22",616224,Neurodevelopmental,AR,,0,1,
361,PRF1,408,"Hemophagocytic lymphohistiocytosis, familial, type 2",603553,"Hematological, Immunological and Lymphatic",AR,,1,0,
362,PRKAR1A,409,"Carney complex, type 1",160980,Dermatological,AD,,0,1,
363,PRKN,410,"Parkinson disease, juvenile, type 2",600116,Neurological,AR,,0,1,
364,PRMT7,411,"Short stature, brachydactyly, intellectual developmental disability, and seizures",617157,Neurodevelopmental,AR,,0,2,
365,PRNP,412,Creutzfeldt-Jakob disease,123400,Neurological,AD,,0,1,
366,PROM1,413,"Stargardt disease, type 4",603786,Ocular,AD,,1,0,
,PROM1,414,"Retinitis pigmentosa, type 41",612095,Ocular,AR,,2,0,
,PROM1,415,"Macular dystrophy, retinal, type 2",608051,Ocular,AD,,5,0,
,PROM1,416,"Cone-rod dystrophy, type 12",612657,Ocular,AR,,11,0,
367,PRPF3,417,"Retinosis pigmentosa, type 18",601414,Ocular,AD,,11,0,
368,PRPF31,418,"Retinitis pigmentosa, type 11",600138,Ocular,AD,,24,0,
369,PRPF6,419,"Retinitis pigmentosa, type 60",613983,Ocular,AD,,1,0,
370,PRPF8,420,"Retinitis pigmentosa, type 13",600059,Ocular,AD,,2,0,
371,PRPH12,421,"Retinitis pigmentosa, type 7",608133,Ocular,AD,,1,0,
372,PRPH2,422,"Macular dystrophy, patterned, type 1",169150,Ocular,AD,,6,0,
373,PRR12,423,Neurocoular syndrome,619539,Neurodevelopmental,AD,,1,0,
374,PRSS56,424,"Microphthalmia, isolated, type 6",613517,Ocular,AR,,10,0,
375,PSAP,425,Metachromatic leukodystrophy due to SAP-b deficiency,249900,Neurodevelopmental,AR,,0,1,
376,PSEN1,426,"Alzheimer disease, type 3, with or without spastic paraparesis",607822,Neurological,AD,,0,1,
377,PSTPIP1,427,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne",604416,Dermatological,AD,,1,0,
378,PTCH1,428,Gorlin Goltz syndrome,109400,Neurodevelopmental,AD,,0,1,
379,PTEN,429,"Cowden syndrome, type 1",158350,Neurodevelopmental,AD,,1,2,
380,PTPN11,430,"Noonan syndrome, type 1",163950,Neurodevelopmental,AD,,0,5,
381,PUM1,431,"Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism",620719,Neurodevelopmental,AD,,0,1,
382,PURA,432,"Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties",616158,Neurodevelopmental,AD,,0,1,
383,PXDN,433,"Anterior segment dysgenesis, type 7",269400,Ocular,AR,,4,0,
384,RAB11B,434,"Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter",617807,Neurodevelopmental,AD,,0,1,
385,RAB3GAP1,435,"Warburg micro syndrome, type 1",600118,Neurodevelopmental,AR,,1,0,
386,RAD51C,436,"{Breast-ovarian cancer, familial, susceptibility to, 3}",613399,Cancer,AD,,0,1,
387,RAX,437,"Microphthalmia, Syndromic, type 16",611038,Ocular,AR,,2,0,
388,RB1,438,Retinoblastoma,180200,Cancer,AD,,3,1,
389,RBP3,439,"Retinitis pigmentosa, type 66",615233,Ocular,AR,,1,0,
390,RDH12,440,Retinitis pigmentosa ,,Ocular,AD,"Sarkar et al., 2020.",2,0,
,RDH12,441,"Leber congenital amaurosis, type 13",612712,Ocular,AR,,32,0,
391,RDH5,442,Fundus albipunctatus,136880,Ocular,AD,,5,0,
392,REEP6,443,"Retinitis pigmentosa, type 77",617304,Ocular,AR,,1,0,
393,RHO,444,"Retinitis pigmentosa, type 4",613731,Ocular,AD,,26,0,
394,RNASEH2A,445,"Aicardi-Goutieres syndrome, type 4",610333,Neurodevelopmental,AR,,1,0,
395,RNF170,446,"Ataxia, sensory, type 1",608984,Neurological,AD,,0,1,
396,RNU6-2,447,Retinitis pigmentosa,,Ocular,AD,Quinodoz et al. 2025,1,0,
397,ROM1,448,"Retinitis pigmentosa, type 7",608133,Ocular,AD,,1,0,
398,RORA,449,Intellectual developmental disorder with or without epilepsy or cerebellar ataxia,618060,Neurodevelopmental,AD,,0,1,
399,RP1,450,"Retinitis pigmentosa, type 1",180100,Ocular,AD,,18,0,
400,RP1L1,451,"Retinitis pigmentosa, type 88",618826,Ocular,AR,,1,0,
401,RP2,452,"Retinitis pigmentosa, type 2",312600,Ocular,XL,,21,0,
402,RPE65,453,"Leber congenital amaurosis, type 2",204100,Ocular,AR,,22,0,
,RPE65,454,"Retinitis pigmentosa, type 20",613794,Ocular,AR,,3,0,
403,RPGR,455,"Retinitis pigmentosa, type 3",312610,Ocular,XL,,30,0,
,RPGR,456,"Macular degeneration, atrophic",300834,Ocular,XL,,3,0,
404,RPGRIP1,457,"Cone-rod dystrophy, type 13",608194,Ocular,AR,,1,0,
,RPGRIP1,458,"Leber congenital amaurosis, type 6",613826,Ocular,AR,,16,0,
405,RRM2B,459,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, type 5",613077,Neurological,AD,,0,1,
406,RS1,460,"Retinoschisis, type 1, juvenile",312700,Ocular,XL,,31,0,
407,RTEL1,461,"Dyskeratosis congenita, type 5",615190,Dermatological,AR,,0,1,
408,RTN41IP1,462,"Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures",616732,Neurodevelopmental,AR,,1,0,
409,RUNX2,463,Cleidocranial dysplasia,119600,Skeletal,AD,,1,0,
410,RYR1,464,"Congenital myopathy, type 1A ",117000,Neurological,AD,,0,3,
,RYR1,465,Malignant hyperthermia susceptibility 1,145600,Neurological,AD,,0,2,
411,SAG,466,"Retinitis pigmentosa, type 96",620228,Ocular,AD,,3,0,
412,SALL4,467,Duane-radial ray syndrome,607323,Skeletal,AD,,2,0,
413,SAMD7,468,Macular dystrophy with or without cone dysfunction,620762,Ocular,AR,,1,0,
414,SCLT1,469,"Retinal dystrophy, non syndromic",,Ocular,AR,"Sangermano et al., 2025",1,0,
415,SCN11A,470,"Episodic pain syndrome, familial, type 3",615552,Neurological,AD,,0,4,
416,SCN1A,471,Dravet syndrome,607208,Neurodevelopmental,AD,,1,5,
,SCN1A,472,"Developmental and epileptic encephalopathy, type 6B, non-Dravet",619317,Neurodevelopmental,AD,,0,1,
417,SCN2A,473,"Developmental and epileptic encephalopathy, type 11",613721,Neurodevelopmental,AD,,0,1,
418,SCN4A,474,Paramyotonia congenita,168300,Neurological,AD,,0,1,
419,SCN5A,475,"Long QT syndrome, type 3",603830,Cardiovascular,AD,,0,1,
,SCN5A,476,"Brugada syndrome, type 1",601144,Cardiovascular,AD,,0,1,
420,SCN9A,477,SCN9A Neuropathic Pain Syndromes,,Neurological,AD,"Hisama et al., 2020",0,3,
421,SDHD,478,"Pheochromocytoma/paraganglioma syndrome, type 1",168000,Endocrine,AD,,1,0,
422,SLC34A1,479,"Nephrolithiasis/osteoporosis, hypophosphatemic, 1 ",612286,Metabolic,AD,,1,0,
423,SERPINA1,480,Alpha-1-Antitrypsin Deficiency,613490,Metabolic,AR,,0,1,
424,SETD1A,481,Neurodevelopmental disorder with speech impairment and dysmorphic facies,619056,Neurodevelopmental,AD,,0,1,
425,SETD1B,482,Intellectual developmental disorder with seizures and language delay,619000,Neurodevelopmental,AD,,0,1,
426,SETD5,483,"Intellectual developmental disorder, type 23",615761,Neurodevelopmental,AD,,0,1,
427,SETX,484,"Spinocerebellar ataxia, with axonal neuropathy, type 2",606002,Neurological,AR,,0,1,
428,SGCE,485,"Dystonia, type 11, myoclonic",159900,Neurological,AD,,0,1,
429,SGSH,486,Mucopolysaccharidosis type IIIA (Sanfilippo A),252900,Neurodevelopmental,AR,,0,1,
430,SHANK3,487,Phelan-McDermid syndrome,606232,Neurodevelopmental,AD,,0,1,
431,SHH,488,"Holoprosencephaly, type 3",142945,Neurodevelopmental,AD,,1,0,
432,SIX1,489,"Branchiootic syndrome, type 3",608389,Skeletal,AD,,0,1,
433,SLC25A15,490,Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Neurodevelopmental,AR,,0,3,
434,SLC45A2,491,"Albinism, oculocutaneous, type IV",606574,Dermatological,AR,,1,0,
435,SLC4A11,492,Corneal endothelial dystrophy,217700,Ocular,AR,,1,0,
436,SLC6A1,493,Myoclonic-atonic epilepsy,616421,Neurological,AD,,0,1,
437,SMAD6,494,"Radioulnar synostosis, nonsyndromic ",179300,Skeletal,AD,,1,0,
438,SMC3,495,"Cornelia de Lange syndrome, type 3",610759,Neurodevelopmental,AD,,0,1,
439,SMPD1,496,Niemann-Pick disease type A,257200,Metabolic ,AR,,1,0,
440,SNRNP200,497,"Retinitis pigmentosa, type 33",610359,Ocular,AD,,14,0,
441,SOHLH1,498,"Ovarian dysgenesis, type 5",617690,Renal and Genitourinary ,AR,,4,0,
442,SOS1,499,"Noonan syndrome, type 4",610733,Neurodevelopmental,AD,,4,4,
443,SOX10,500,"Waardenburg syndrome, type 2E, with or without neurologic involvement",611584,Dermatological,AD,,0,2,
444,SOX2,501,"Microphthalmia, Syndromic, type 3",206900,Ocular,AD,,4,0,
,SOX2,502,Optic nerve hypoplasia and abnormalities of the central nervous system,206900,Ocular,AD,,1,0,
445,SOX4,503,"Coffin-Siris syndrome, type 10 ",618506,Neurodevelopmental,AD,,1,0,
446,SOX9,504,"46XY sex reversal, type 10 ",616425,Renal and Genitourinary,AD,,1,0,
447,SPATA7,505,"Leber congenital amaurosis, type 3",604232,Ocular,AR,,5,0,
,SPATA7,506,"Retinitis pigmentosa, type 94",604232,Ocular,AR,,3,0,
448,SPECC1L,507,"Teebi hypertelorism syndrome, type 1",145420,Skeletal,AD,,1,0,
449,SPG7,508,"Spastic paraplegia, type 7",607259,Neurological,AR,,1,0,
450,SPTAN1,509,"Developmental and epileptic encephalopathy, type 5",613477,Neurodevelopmental,AD,,0,2,
451,SPTB,510,"Spherocytosis, type 2",616649,"Hematological, Immunological and Lymphatic",AD,,0,3,
452,SPTLC1,511,"Neuropathy, hereditary sensory and autonomic, type IA",162400,Neurological,AD,,0,1,
453,SREBF1,512,"Mucoepithelial dysplasia, hereditary",158310,Dermatological,AD,,2,0,
454,SRRM2,513,"Intellectual developmental disorder, type 72",620439,Neurodevelopmental,AD,,0,2,
455,STAMBP,514,Neurodevelopmental disorder associated to STAMBP,,Neurodevelopmental,AR,"Hu et al., 2022",0,2,
456,STK11,515,Peutz-Jeghers syndrome,175200,Cancer,AD,,1,1,
457,STS,516,Icthyosis,308100,Dermatological,XL,,1,0,
458,STXBP1,517,"Developmental and epileptic encephalopathy, type 4",612164,Neurodevelopmental,AD,,0,1,
459,SUCLG1,518,"Mitochondrial DNA depletion syndrome, type 9 (encephalomyopathic type with methylmalonic aciduria)",245400,Neurodevelopmental,AR,,0,1,
460,SUOX,519,Sulfite oxidase deficiency,272300,Neurodevelopmental,AR,,0,1,
461,SYNE1,520,"Emery-Dreifuss muscular dystrophy, type 4",612998,Neurological,AD,,0,1,
462,TACSTD2,521,"Corneal dystrophy, gelatinous drop-like",204870,Ocular,AR,,10,0,
463,TBC1D24,522,"Developmental and epileptic encephalopathy, type 16",615338,Neurodevelopmental,AR,,0,7,
,TBC1D24,523,"Myoclonic epilepsy, infantile, familial",605021,Neurodevelopmental,AR,,0,1,
464,TBCD,524,"Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum",617193,Neurodevelopmental,AR,,0,1,
465,TBL1XR1,525,"Intellectual developmental disorder, type 41",616944,Neurodevelopmental,AD,,0,1,
466,TBP,526,"Spinocerebellar ataxia, type 17",607136,Neurological,AD,,0,2,
467,TBX18,527,"Congenital anomalies of kidney and urinary tract, type 2",143400,Renal and Genitourinary,AD,,0,2,
468,TBXAS1,528,Ghosal hematodiaphyseal syndrome,231095,"Hematological, Immunological and Lymphatic",AR,,0,1,
469,TCF20,529,Developmental delay with variable intellectual impairment and behavioral abnormalities,618430,Neurodevelopmental,AD,,0,1,
470,TEK,530,"Glaucoma, type 3, primary congenital, E",617272,Ocular,AD,,16,0,
471,TFAP2A,531,Branchiooculofacial syndrome,113620,Ocular,AD,,7,0,
472,TFAP2B,532,Char syndrome,169100,Cardiovascular,AD,,0,1,
473,TGFBI,533,"Corneal dystrophy, Reis Bucklers type",608470,Ocular,AD,,11,0,3462
,TGFBI,534,"Corneal dystrophy, Avelino type Granular type 2",607541,Ocular,AD,,12,0,
,TGFBI,535,"Corneal dystrophy, Granular type 1",121900,Ocular,AD,,35,0,
,TGFBI,536,"Corneal dystrophy, Lattice type 1",122200,Ocular,AD,,20,0,
,TGFBI,537,"Corneal dystrophy, Thiel Benke type",602082,Ocular,AD,,1,0,
474,TGM1,538,"Ichthyosis, congenital, type 1",242300,Dermatological,AR,,13,0,
475,TIMP3,539,Sorsby fundus dystrophy,136900,Ocular,AD,,1,0,
476,TK2,540,"Mitochondrial DNA depletion syndrome, type 2 (myopathic type)",609560,Muscular,AR,,1,0,
477,TMC6,541,Epidermodysplasia verruciformis,226400,Dermatological,AR,,2,0,
478,TMEM127,542,"{Pheochromocytoma, susceptibility to}",171300,Endocrine,AD,,0,1,
479,TMEM231,543,"Joubert syndrome, type 20",614970,Neurodevelopmental,AR,,2,0,
480,TMEM67,544,"COACH syndrome, type 1",216360,Neurodevelopmental,AR,,0,1,
481,TNFRSF13B,545,"Inmunodeficiency, common variable, type 2",240500,"Hematological, Immunological and Lymphatic",AD,,0,1,
482,TNFRSF1A,546,"Periodic fever, familial",142680,"Hematological, Immunological and Lymphatic",AD,,0,1,
483,TNNI3,547,"Cardiomyopathy, hypertrophic, type 7 ",613690,Cardiovascular,AD,,0,1,
484,TNNI3K,548,Cardiac conduction disease with/without dilated cardiomiopathy,616117,Cardiovascular,AD,,1,0,
485,TOPORS,549,"Retinitis pigmentosa, type 31",609923,Ocular,AD,,10,0,
486,TP53,550,Li-Fraumeni syndrome,151623,Cancer,AD,,1,0,
487,TP63,551,"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome, type 3",604292,Skeletal,AD,,5,0,
,TP63,552,ADULT syndrome,103285,Skeletal,AD,,1,0,
488,TRRAP,553,Developmental delay with or without dysmorphic facies and autism,618454,Neurodevelopmental,AD,,0,3,
489,TSC1,554,"Tuberous sclerosis, type 1",191100,Cancer,AD,,0,1,
490,TTC8,555,"Bardet-Biedl syndrome, type 8",615985,Endocrine,AR,,1,0,
491,TTPA,556,Ataxia with isolated vitamin E deficiency,277460,Neurological,AR,,0,2,
492,TTR,557,"Amyloidosis, hereditary, transthyretin-related",105210,Cardiovascular,AD,,3,3,
,TTR,558,Müller cell dystrophy,,Ocular,AD,"Dalma-Weiszhausz et al., 2022",1,0,
493,TUBA1A,559,Lissencephaly 3,611603,Neurodevelopmental,AD,,0,1,
494,TUBB,560,"Cortical dysplasia, complex, with other brain malformations, type 6 ",615771,Neurodevelopmental,AD,,1,0,
495,TUBB3,561,"Fibrosis of extraocular muscles, congenital, type 3A ",600638,Ocular,AD,,1,0,
496,TULP1,562,"Retinitis pigmentosa, type 14",600132,Ocular,AR,,3,0,
,TULP1,563,Cone-rod dystrophy,,Ocular,AR,"Boulanger-Scemama et al., 2015 ",1,0,
,TULP1,564,"Leber congenital amaurosis, type 15",613843,Ocular,AR,,9,0,
497,TWIST2,565,Barber-Say syndrome,209885,Dermatological,AD,,1,0,
498,TYR,566,"Albinism, oculocutaneous, type IA",203100,Dermatological,AR,,1,0,
499,UBIAD1,567,"Corneal dystrophy, Schnyder type",121800,Ocular,AD,,5,0,
500,UBQLN2,568,"Amyotrophic lateral sclerosis, type 15, with or without frontotemporal dementia ",300857,Neurological,XL,,1,0,
501,UGT1A1,569,"Crigler-Najjar syndrome, type I",218800,Metabolic,AR,,3,0,
502,UNC119,570,"Cone-rod dystrophy, type 24",620342,Ocular,AD,,1,0,
503,USH1C,571,"Usher syndrome, type 1C",276904,Ocular,AR,,1,0,
504,USH2A,572,Usher syndrome type 2A,276901,Ocular,AR,,46,0,
,USH2A,573,"Retinitis pigmentosa, type 39",613809,Ocular,AR,,51,0,
505,VHL,574,Von Hippel-Lindau syndrome,193300,Cancer,AD,,40,0,
506,VMA21,575,"Myopathy, with excessive autophagy",310440,Muscular,XL,,0,1,
507,VPS13B,576,Cohen syndrome,216550,Neurodevelopmental ,AR,,2,0,
508,VSX1,577,Craneofacial anomalies and anterior segment dysgenesis syndrome ,614195,Ocular,AD,,1,0,
509,VSX2,578,"Micropthalmia, isolated, type 2",610093,Ocular,AR,,1,0,
510,VWA8,579,"Retinitis pigmentosa, type 97",620422,Ocular,AD,,3,1,
511,WDR19,580,Retinitis pigmentosa,,Ocular,AR,"Coussa et al., 2013",3,0,
512,WDR45,581,"Neurodegeneration with brain iron accumulation, type 5",300894,Neurodevelopmental,XL,,0,2,
513,WFS1,582,"Wolfram syndrome, type1",222300,Ocular,AR,,11,0,
514,ZC4H2,583,"Wieacker-Wolff syndrome, female-restricted",301041,Neurodevelopmental,XL,,0,1,
515,ZNF469,584,"Brittle cornea syndrome, type 1",229200,Ocular,AR,,3,0,
516,1p31.1-p31.3 deletion,585,Chromosome 1p31 deletion syndrome,,Neurodevelopmental,AD,"Genovese et al., 2015",0,1,
517,1p36.33 deletion,586,"Chromosome 1p36 deletion syndrome, distal",607872,Neurodevelopmental,AD,,0,1,
518,1q21 deletion,587,Chromosome 1q21.1 deletion syndrome,612474,Neurodevelopmental,AD,,0,1,
519,2q24.1-q24.2 deletion,588,Chromosome 2q24.1-q24.2 deletion syndrome,,Neurodevelopmental,AD,"Palumbo et al., 2012 ",0,1,
520,3q29 deletion,589,Chromosome 3q29 microdeletion syndrome,609425,Neurodevelopmental,AD,,0,1,
521,4p16.3 deletion,590,Chromosome 4p16.3 deletion syndrome,194190,Neurodevelopmental,AD,,0,1,
522,8q21.3-8q22.1 deletion,591,Chromosome 8q22.1 deletion syndrome,,Neurodevelopmental,AD,"Overhoff et al., 2014",0,1,
523,11p13 deletion,592,"Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome",194072,Renal and Genitourinary,AD,,0,1,
524,13q32.1 deletion,593,"Microcoria, congenital ",156600,Ocular,AD,,1,0,
525,15q11.2 deletion,594,Chromosome 15q11.2 deletion syndrome,615656,Neurodevelopmental,AD,,0,1,
526,15q11.2-q13 deletion (maternal),595,Angelman syndrome,105830,Neurodevelopmental,AD,,0,2,
527,15q11.2-q13 deletion (paternal),596,Prader-Willi syndrome,176270,Neurodevelopmental,AD,,0,7,
528,15q11.2-q13 duplication,597,Chromosome 15q11-q13 duplication syndrome,608636,Neurodevelopmental,AD,,0,5,
529,16p11.2 deletion,598,Chromosome 16p11.2 deletion syndrome,611913,Neurodevelopmental,AD,,0,6,
530,16p13.11 duplication,599,Chromosome 16p13.11 duplication syndrome,,Neurodevelopmental,AD,"Allach El Khattabi et al., 2020",0,7,
531,17p12 duplication,600,"Charcot-Marie-Tooth disease, type 1A",118220,Neurological,AD,,0,8,
532,17p13.3 deletion,601,Chromosome 17p13.3 deletion syndrome,247200,Neurodevelopmental,AD,,0,9,
533,18p11.32 deletion,602,Chromosome 18p deletion syndrome,146390,Neurodevelopmental,AD,,0,10,
534,18q22.1 deletion,603,Chromosome 18q deletion syndrome,601808,Neurodevelopmental,AD,,0,11,
535,22q11.2 deletion,604,Chromosome 22q11.2 deletion syndrome,188400,Neurodevelopmental,AD,,1,12,
536,Xp22.31 deletion,605,Chromosome Xp22.31 deletion syndrome,,Neurodevelopmental,XL,"Ma et al., 2020",0,13,
